Canopy Growth Corp.

Five years into its legalization, the Canadian cannabis market reveals intriguing regional disparities and growth trends, as highlighted in the latest report from cannabis equity research firm Zuanic & Associates. Despite the usual market drivers like affordability, access, and variety, Canada...

The recent equity raises by Canopy Growth (NASDAQ: CGC) and Columbia Care (OTC: CCHWF) have sparked curiosity about which multi-state operators (MSOs) may follow suit. In its latest report, Zuanic & Associates (Z&A) delves into the financial net debt metrics of 20 MSOs to identify potential...

US legal cannabis sales are predicted to exceed $28 billion in 2023, with promising regulatory developments such as the recommendation to "reschedule" cannabis by the HHS. Canada's cannabis exports have surged to C$160 million, a 50% increase year-on-year, and with new international...

Once bullish on the US hemp-derived CBD market, Canadian cannabis companies like Canopy Growth Corp. (NASDAQ: CGC), Aurora Cannabis Inc. (NASDAQ: ACB), and Cronos Group (NASDAQ: CRON) are now retreating due to oversupply, regulatory ambiguity and the sluggish pace of US federal cannabis...